MENU
+Compare
FBT
ETF ticker: NYSE ARCA
AS OF
Sep 17 closing price
Price
$176.45
Change
-$0.40 (-0.23%)
Net Assets
1.07B

FBT stock forecast, quote, news & analysis

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index... Show more

Category: #Health
FBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for FBT with price predictions
Sep 17, 2025

FBT sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for FBT moved above the 200-day moving average on September 05, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 02, 2025. You may want to consider a long position or call options on FBT as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

FBT moved above its 50-day moving average on August 12, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FBT advanced for three days, in of 324 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 204 cases where FBT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for FBT moved out of overbought territory on September 08, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 64 cases where FBT's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for FBT turned negative on September 12, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FBT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FBT broke above its upper Bollinger Band on September 05, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Regeneron Pharmaceuticals (NASDAQ:REGN), Biogen (NASDAQ:BIIB), Incyte Corp (NASDAQ:INCY), Illumina (NASDAQ:ILMN), Exelixis (NASDAQ:EXEL), Exact Sciences Corp (NASDAQ:EXAS), Moderna (NASDAQ:MRNA), Sarepta Therapeutics (NASDAQ:SRPT).

Industry description

The investment seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called the NYSE ® Arca ® Biotechnology Index. The fund will normally invest at least 90% of its net assets (including investment borrowings) in the securities that comprise the index. The index is an equal-dollar weighted index designed to measure the performance of 30 leading biotechnology companies.

Market Cap

The average market capitalization across the First Trust NYSE Arca Biotech ETF ETF is 28.02B. The market cap for tickers in the group ranges from 1.89B to 147.02B. AMGN holds the highest valuation in this group at 147.02B. The lowest valued company is SRPT at 1.89B.

High and low price notable news

The average weekly price growth across all stocks in the First Trust NYSE Arca Biotech ETF ETF was 1%. For the same ETF, the average monthly price growth was 2%, and the average quarterly price growth was 5%. KRYS experienced the highest price growth at 12%, while EXAS experienced the biggest fall at -4%.

Volume

The average weekly volume growth across all stocks in the First Trust NYSE Arca Biotech ETF ETF was 13%. For the same stocks of the ETF, the average monthly volume growth was 26% and the average quarterly volume growth was -41%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 65
P/E Growth Rating: 67
Price Growth Rating: 55
SMR Rating: 59
Profit Risk Rating: 65
Seasonality Score: -32 (-100 ... +100)
View a ticker or compare two or three
FBT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
First Trust Exchange-Traded Fund1001 Warrenville Road, Suite 300Lisle
Phone
630-241-4141
Web
www.ftportfolios.com